Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
Recent hypertension guidelines recommend combination therapy as initial treatment for many or
most patients. Several trials suggest triple low-dose combination therapy may be highly
effective in terms of achieving blood pressure control without increasing adverse effects.
This trial is designed to investigate the efficacy and safety of GMRx2 in participants with
high blood pressure compared to dual combinations.